Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02065765
Title International Expanded Access Program to Provide Ramucirumab for the Treatment of Metastatic Gastric Cancer
Recruitment No longer available
Gender both
Phase Phase II
Variant Requirements No
Sponsors Eli Lilly and Company
Indications

stomach carcinoma

gastric adenocarcinoma

gastroesophageal junction adenocarcinoma

Therapies

Ramucirumab

Age Groups: adult
Covered Countries DEU | AUT


No variant requirements are available.